Motolimod

INN name:	Motolimod
Lab codes:	VTX-2337
Chemical name:	2-amino-N,N-dipropyl-8-[4-(pyrrolidine-1-carbonyl)phenyl]-3H-1-benzazepine-4-carboxamide
Molecular formula:	C28H34N4O2
Chemical Structure:
CAS Registry Number:	926927-61-9
Originator:	Array BioPharma
Developer:	VentiRx Pharmaceuticals
Class:	Antineoplastics, immunomodulator
Mechanism of Action:	Toll-like receptor 8 (TLR8) agonist
WHO ATC code:	L03A-X
EPhMRA code:	L3A9
Clinical Trials: Conditions Phases Interventions Recruitment Epithelial Ovarian Cancer|Fallopian Tube Cancer|Primary Peritoneal Cancer Phase 2 Combination Active, not recruiting Carcinoma, Squamous Cell of Head and Neck Phase 2 Combination Active, not recruiting Ovarian Cancer Phase 1|Phase 2 Combination Not yet recruiting Low Grade B Cell Lymphoma Phase 1|Phase 2 Combination Terminated  Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and Neck Phase 1 Combination Completed Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer Phase 1 Combination Completed Squamous Cell Carcinoma of the Head and Neck Phase 1 Combination Recruiting Advanced Solid Tumors|Lymphoma Phase 1 Alone Completed